CVS Health (CVS) is drawing investor attention after recent trading left the stock around $98.32, with performance over the past month and past 3 months contrasting with short term weekly declines.

Short term momentum for CVS Health has eased, with the share price declining 0.85% over the last day and 2.34% over the week. However, the 90 day share price return of 35.05% and 1 year total shareholder return of 52.55% point to a much stronger recent run overall.

If you are comparing CVS Health with other ideas in the market, this could be a useful time to look across healthcare technology and screening tools such as 38 healthcare AI stocks

With CVS Health trading near $98 and data pointing to a sizable intrinsic value discount alongside upbeat analyst targets, the big question is whether the stock is still undervalued or if the market is already pricing in expectations for future performance.

Most Popular Narrative: 5.5% Undervalued

The current CVS Health share price of $98.32 sits slightly below a narrative fair value estimate of $104.01, which frames the stock as modestly discounted rather than deeply mispriced.

CVS Health’s recent stock drop reveals a healthcare company that some investors may view as undervalued, particularly if its $2 billion restructuring plan is perceived as likely to support profitability and stabilize growth.

Want to see what sits behind that fair value for CVS Health? The narrative focuses on earnings power, revenue resilience and margins tied to an integrated healthcare model. Curious which assumptions really move the valuation needle? The full story explains how those elements are used to arrive at the $104.01 figure.

Result: Fair Value of $104.01 (UNDERVALUED)

However, CVS Health’s story could look very different if medical costs stay elevated or if the $2b restructuring and integration efforts fail to deliver efficiencies.

Another View: CVS Health Looks Expensive On Earnings

While one narrative frames CVS Health as modestly undervalued, its current P/E ratio of 42.8x tells a different story. That is higher than both the estimated fair ratio of 37.5x and the US Healthcare industry average of 23.4x, which points to valuation risk if earnings stumble again.

For investors, the question is simple: is this a margin of safety or a margin of error hiding in plain sight?

Next Steps

With mixed signals around CVS Health in this article, it may be useful to act promptly and evaluate the trade off between risks and potential rewards. To see both sides clearly, review the 2 key rewards and 5 important warning signs

Looking for more investment ideas beyond CVS Health?

If CVS Health has your attention, do not stop there. Broadening your watchlist with different types of opportunities can help you stress test your thinking and avoid tunnel vision.

Use the Simply Wall St Screener to quickly surface stocks that fit clear, helpful criteria that you can compare side by side.

• Target potential mispricing by scanning companies that combine strong fundamentals with attractive valuations through the 45 high quality undervalued stocks.
• Prioritize resilience by focusing on businesses with sturdy finances using the solid balance sheet and fundamentals stocks screener (48 results).
• Spot opportunities that others may be overlooking by checking the screener containing 19 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.